Skip to content
Inciteful Med

Long-Term Monitoring and Survivorship

Last updated:

Long-term monitoring for Hemoglobin C varies by genotype. HbCC requires basic wellness checks, while HbSC requires strict, ongoing surveillance—especially annual dilated eye exams starting at age 10, spleen checks, and kidney screenings—to prevent serious silent complications.

Key Takeaways

  • • Hemoglobin C disease (HbCC) generally causes mild anemia and requires routine, less intensive medical monitoring.
  • • Hemoglobin SC (HbSC) carries a higher risk of silent complications, requiring strict annual screenings for vision, kidney, and joint health.
  • • Annual dilated eye exams starting at age 10 are crucial for HbSC patients due to a high risk of proliferative retinopathy.
  • • Routine Transcranial Doppler (TCD) screenings are not recommended for children with HbSC, as their stroke risk profile differs from other sickle cell types.
  • • Pregnancy with HbSC requires high-risk obstetric care due to increased risks of preeclampsia and lower birth weights.

Managing Hemoglobin C is a lifelong journey. Because the condition is often labeled as “mild,” patients and parents may be tempted to skip screenings once they feel well. However, the goal of long-term monitoring is not just to treat symptoms but to prevent complications before they start. While HbCC requires less intensive follow-up, HbSC requires a disciplined surveillance schedule to protect your vision, organs, and joints.

Lifetime Surveillance Schedule for HbCC

For those with Hemoglobin C disease (HbCC), monitoring is straightforward and focused on general wellness:

What to Check When to Start How Often Why?
Complete Blood Count (CBC) At diagnosis Every 1-2 years To monitor your baseline mild anemia and check for changes [1].
Eye Exam At diagnosis Baseline, then as directed To check for rare but possible retinal issues [2].
Physical Exam Childhood Annually To check the spleen for painless enlargement (splenomegaly) [3].
Gallbladder Check Adulthood If symptoms arise To monitor for gallstones (cholelithiasis) caused by red blood cell breakdown [4].

(Note: If you have HbCC, the following complications do NOT apply to you. HbSC is a form of sickle cell disease with different risks.)

Lifetime Surveillance Schedule for HbSC

Unlike other forms of sickle cell disease, HbSC complications often appear later in life and can be “silent” until they are advanced [5][6]. Note: Current guidelines explicitly advise against routine Transcranial Doppler (TCD) screenings for children with HbSC, because their stroke risk is much lower than in HbSS, and TCD results do not reliably predict stroke in HbSC patients [7].

What to Check When to Start How Often Why?
Dilated Eye Exam Age 10 [8] Every year [9] To catch proliferative retinopathy before it causes vision loss [10].
Spleen Exam At diagnosis Every 6–12 months To monitor for splenomegaly (enlarged spleen) or sequestration [5].
Kidney Screen Childhood Every year To check for proteinuria (protein in urine), an early sign of kidney stress [11].
Joint Check At every visit Every 6 months To look for early signs of avascular necrosis (bone death) in hips or shoulders [12].

Long-Term Complications: HbSC vs. HbCC

It is important to understand the difference in risk between the two genotypes to avoid unnecessary panic or dangerous complacency.

Hemoglobin SC (HbSC)

  • Vision: HbSC patients actually have a higher risk of “proliferative” eye damage than those with the more severe HbSS [10][13].
  • Spleen: Unlike other types, the spleen in HbSC stays functional longer, meaning adults remain at risk for sequestration crises (blood trapping) [14][15].
  • Silent Stroke: While major strokes are rare, “silent” infarcts (small areas of brain damage) can occur and may impact learning or memory [16].

Hemoglobin CC (HbCC)

  • General Health: Long-term complications for HbCC are much rarer and less studied [17]. Most people live typical lifespans with only mild anemia [18].
  • Spleen: Some adults may develop a permanently enlarged spleen, which is usually painless but should be monitored [3].

Pregnancy and Hemoglobin C

  • For Women with HbCC: Pregnancy is typically uncomplicated. The main concern is a slightly higher risk of mild jaundice for the newborn, and standard prenatal care is usually sufficient [19].
  • For Women with HbSC: This requires “high-touch” medical care. There is an increased risk for preeclampsia (high blood pressure) and lower birth weights [20][21]. A multidisciplinary team (hematologist and high-risk OB) is essential [22]. Transfusions are used if significant complications arise, rather than as a routine preventative measure [23][24].

The Psychological Toll and Quality of Life

Living with a chronic blood disorder carries a heavy emotional weight. Even when the condition is “mild,” the uncertainty of when a pain crisis or complication might occur can lead to anxiety and depression [25][26].

  • Impact: Chronic pain and frequent doctor visits can interfere with school, work, and social lives [27][28].
  • Empowerment: Studies show that having strong social support is linked to a better quality of life [29][30].
  • Transitioning Care: As children with HbSC become adults, the “hand-off” from a pediatrician to an adult hematologist is a high-risk time. Ensuring the new doctor understands the unique HbSC (not just HbSS) profile is critical [5].

When to Contact Your Doctor

Between scheduled appointments, you should call your care team immediately if you notice:

  1. Sudden Vision Changes: Any new “floaters,” dark spots, or blurry patches [31].
  2. Abdominal Pain: Pain or a feeling of “fullness” in the upper left side [32].
  3. New Joint Pain: Persistent pain in the hip or shoulder that doesn’t go away with rest [12].
  4. Mental Health Struggles: If the stress of the condition feels unmanageable or stops you from doing things you love.

Frequently Asked Questions

What is the difference in long-term monitoring between HbCC and HbSC?
HbCC monitoring focuses on general wellness, spleen checks, and mild anemia screening every few years. HbSC requires a strict, lifelong schedule including annual dilated eye exams, kidney screens, and frequent spleen and joint checks to prevent serious complications.
When should a child with HbSC start getting eye exams?
Children with HbSC should begin having annual dilated eye exams at age 10. This is a critical step to catch a condition called proliferative retinopathy early, before it can cause permanent vision loss.
Do children with HbSC need routine TCD stroke screenings?
No, current medical guidelines explicitly advise against routine Transcranial Doppler (TCD) screenings for children with HbSC. Their stroke risk is much lower than in other types of sickle cell disease, and TCD results do not reliably predict strokes for HbSC patients.
What are the signs of a spleen problem in Hemoglobin C disease?
Signs of a spleen complication, such as a sequestration crisis, include sudden abdominal pain or a feeling of fullness in the upper left side of your stomach. If you notice these symptoms, you should contact your care team immediately.
Is it safe to get pregnant if I have Hemoglobin C disease?
Pregnancy is typically uncomplicated for women with HbCC. However, women with HbSC have a higher risk for preeclampsia and low birth weights, requiring close monitoring by a team that includes a hematologist and a high-risk obstetrician.
Why do I need to have my joints checked if I have HbSC?
People with HbSC are at risk for avascular necrosis, a condition that causes bone death, most commonly in the hips or shoulders. Routine joint checks every six months can help identify early signs before permanent damage occurs.

Questions for Your Doctor

  • • (For HbCC) How often should I have a Complete Blood Count (CBC) to monitor my baseline anemia?
  • • (For HbSC) Based on my child's HbSC diagnosis, should we start yearly dilated eye exams at age 10 or earlier?
  • • (For HbSC) What are the specific 'red flags' for a splenic sequestration crisis that I should watch for at home?
  • • (For HbSC) Are there specific kidney health markers, like microalbuminuria, that you monitor annually?
  • • (For HbSC) If I experience persistent hip or shoulder pain, what is the first step to rule out avascular necrosis?

Questions for You

  • • How often do I get a thorough, dilated eye exam by a specialist?
  • • Do I have a primary care doctor and a hematologist who communicate with each other?
  • • Have I noticed any persistent joint pain that doesn't feel like a typical 'crisis'?
  • • How much does worrying about the 'next crisis' affect my daily life or my child's school attendance?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Hemoglobin C Disorder in Anemic Patients Referred to the National Center for Thalassemia and Genetic Counseling in Damascus.

    Ahmad A, Fattoum K, Imam W, et al.

    International journal of hematology-oncology and stem cell research 2024; (18(2)):183-191 doi:10.18502/ijhoscr.v18i2.15376.

    PMID: 38868813
  2. 2

    Tractional Retinal Detachment Related to Hemoglobin C Trait Retinopathy: A Case Report.

    Garrell-Salat X, Garcia-Arumi C, Bertolani Y, et al.

    Turkish journal of ophthalmology 2023; (53(5)):318-321 doi:10.4274/tjo.galenos.2023.48672.

    PMID: 37870045
  3. 3

    Hemoglobinosis C in Morocco : A report of 111 cas.

    Ouzzif Z, El Maataoui A, Oukhedda N, et al.

    La Tunisie medicale 2017; (95(12)):229-233.

    PMID: 29878289
  4. 4

    Prevalence of Cardiovascular Complications in Individuals with Sickle Cell Anemia and Other Hemoglobinopathies: A Systematic Review.

    Lopes A, Dantas MT, Ladeia AMT

    Arquivos brasileiros de cardiologia 2022; (119(6)):893-899 doi:10.36660/abc.20220207.

    PMID: 36417618
  5. 5

    The clinical spectrum of HbSC sickle cell disease-not a benign condition.

    Nelson M, Noisette L, Pugh N, et al.

    British journal of haematology 2024; (205(2)):653-663 doi:10.1111/bjh.19523.

    PMID: 38898714
  6. 6

    Acute compartment syndrome in a patient with sickle cell disease.

    Cochrane E, Young S, Shariff Z

    Annals of the Royal College of Surgeons of England 2020; (102(9)):e1-e2 doi:10.1308/rcsann.2020.0160.

    PMID: 32777927
  7. 7

    Transcranial Doppler in hemoglobin SC disease.

    Vieira C, de Oliveira CN, de Figueiredo LA, et al.

    Pediatric blood & cancer 2017; (64(5)) doi:10.1002/pbc.26342.

    PMID: 27957790
  8. 8

    Investigation of Sickle Cell Retinopathy in Pediatric and Adolescent Patients Enrolled in a Large Cohort Study.

    Smith BD, Hankins JS, Kang G, et al.

    Ophthalmology 2025; (132(8)):911-920 doi:10.1016/j.ophtha.2025.03.031.

    PMID: 40188852
  9. 9

    Clinical and laboratory risk factors for sickle cell retinopathy and maculopathy: a scoping review of the current evidence.

    Brandsen RP, Diederen RMH, Kocabas G, et al.

    Haematologica 2025; (110(5)):1092-1104 doi:10.3324/haematol.2024.286420.

    PMID: 39704162
  10. 10

    Ophthalmic Manifestations of Sickle Cell Disease.

    Scott AW

    Southern medical journal 2016; (109(9)):542-8 doi:10.14423/SMJ.0000000000000525.

    PMID: 27598358
  11. 11

    Progressive Decline in Estimated GFR in Patients With Sickle Cell Disease: An Observational Cohort Study.

    Derebail VK, Ciccone EJ, Zhou Q, et al.

    American journal of kidney diseases : the official journal of the National Kidney Foundation 2019; (74(1)):47-55 doi:10.1053/j.ajkd.2018.12.027.

    PMID: 30797615
  12. 12

    Cohort study of adult patients with haemoglobin SC disease: clinical characteristics and predictors of mortality.

    Gualandro SF, Fonseca GH, Yokomizo IK, et al.

    British journal of haematology 2015; (171(4)):631-7 doi:10.1111/bjh.13625.

    PMID: 26255986
  13. 13

    Correlation of Ultra-Widefield Fluorescein Angiography and OCT Angiography in Sickle Cell Retinopathy.

    Han IC, Linz MO, Liu TYA, et al.

    Ophthalmology. Retina 2018; (2(6)):599-605 doi:10.1016/j.oret.2017.10.011.

    PMID: 31047613
  14. 14

    Uncommon Presentation of Hypersplenism in Adult Sickle Cell Disease Patients: A Rare Case Report.

    Qureshi A, Kasbawala K, Santos MT, et al.

    The American journal of case reports 2024; (25()):e944693 doi:10.12659/AJCR.944693.

    PMID: 39300742
  15. 15

    Acute Splenic Sequestration Crisis in Hemoglobin SC Disease: Efficiency of Red Cell Exchange.

    Vijayanarayanan A, Omosule AJ, Saad H, et al.

    Cureus 2020; (12(12)):e12224 doi:10.7759/cureus.12224.

    PMID: 33500853
  16. 16

    Unusually High Prevalence of Stroke and Cerebral Vasculopathy in Hemoglobin SC Disease: A Retrospective Single Institution Study.

    Sathi BK, Yoshida Y, Weaver MR, et al.

    Acta haematologica 2022; (145(2)):160-169 doi:10.1159/000519360.

    PMID: 34749363
  17. 17

    Assessment of iron status and interplay between lipid peroxidation and antioxidant capacity in common hemoglobin variants in Osun State, southwestern Nigeria.

    Ajibola KA, Adedokun KA, Oduola T, et al.

    The Kaohsiung journal of medical sciences 2019; (35(6)):358-364 doi:10.1002/kjm2.12062.

    PMID: 30913360
  18. 18

    Regional Prevalence of Hemoglobin C Across Saudi Arabia: An Epidemiological Survey.

    Aljabry M, Sulimani S, Alotaibi G, et al.

    Journal of epidemiology and global health 2024; (14(2)):298-303 doi:10.1007/s44197-024-00193-w.

    PMID: 38372896
  19. 19

    Biomarkers of oxidative stress and its nexus with haemoglobin variants and adverse foeto-maternal outcome among women with preeclampsia in a Ghanaian population: A multi-centre prospective study.

    Abdul G, Osei-Wusu W, Asare GA, et al.

    PloS one 2023; (18(3)):e0283638 doi:10.1371/journal.pone.0283638.

    PMID: 36996011
  20. 20

    The emerging challenge of optimal blood pressure management and hypertensive syndromes in pregnant women with sickle cell disease: a review.

    Lari NF, DeBaun MR, Oppong SA

    Expert review of hematology 2017; (10(11)):987-994 doi:10.1080/17474086.2017.1379895.

    PMID: 28905692
  21. 21

    Pregnancy in sickle cell-haemoglobin C (SC) disease. A retrospective study of birth size and maternal weight gain.

    Thame MM, Singh-Minott I, Osmond C, et al.

    European journal of obstetrics, gynecology, and reproductive biology 2016; (203()):16-9.

    PMID: 27235631
  22. 22

    Complications in pregnant women with sickle cell disease.

    Smith-Whitley K

    Hematology. American Society of Hematology. Education Program 2019; (2019(1)):359-366 doi:10.1182/hematology.2019000039.

    PMID: 31808864
  23. 23

    The effects of exchange transfusion for prevention of complications during pregnancy of sickle hemoglobin C disease patients.

    Benites BD, Benevides TC, Valente IS, et al.

    Transfusion 2016; (56(1)):119-24 doi:10.1111/trf.13280.

    PMID: 26337929
  24. 24

    Proactive management to improve outcomes of high-risk pregnancy in people with sickle cell disease.

    Obadina MA, Pecker LH

    Hematology. American Society of Hematology. Education Program 2025; (2025(1)):511-522 doi:10.1182/hematology.2025000744.

    PMID: 41348028
  25. 25

    Psychosocial and mental profile of children with sickle cell disease and their caregivers.

    Ebeid FSE, Mokhtar GM, Zaky EA, et al.

    Pediatric hematology and oncology 2024; (41(1)):15-29 doi:10.1080/08880018.2023.2261975.

    PMID: 37773584
  26. 26

    Barriers to hydroxyurea adherence and health-related quality of life in adolescents and young adults with sickle cell disease.

    Badawy SM, Thompson AA, Penedo FJ, et al.

    European journal of haematology 2017; (98(6)):608-614 doi:10.1111/ejh.12878.

    PMID: 28306171
  27. 27

    Health-Related Quality of Life Among Patients With Sickle Cell Disease in an Adult Hematology Clinic in a Tertiary Hospital in Lagos, Nigeria.

    Amaeshi L, Kalejaiye OO, Ogamba CF, et al.

    Cureus 2022; (14(1)):e21377 doi:10.7759/cureus.21377.

    PMID: 35198289
  28. 28

    Health-Related Quality of Life of Children and Adolescents with Sickle Cell Disease in the Middle East and North Africa Region: A systematic review.

    Pandarakutty S, Murali K, Arulappan J, Al Sabei SD

    Sultan Qaboos University medical journal 2020; (20(4)):e280-e289 doi:10.18295/squmj.2020.20.04.002.

    PMID: 33414931
  29. 29

    Health-related quality of life and adherence to hydroxyurea in adolescents and young adults with sickle cell disease.

    Badawy SM, Thompson AA, Lai JS, et al.

    Pediatric blood & cancer 2017; (64(6)) doi:10.1002/pbc.26369.

    PMID: 27896936
  30. 30

    Exploring the impact of stigma on health-related quality of life among individuals with sickle cell disease: a moderated mediation analysis of distress and social support.

    Onu DU, Nnadozie EE, Obi-Keguna CN, Igwe EJ

    Psychology, health & medicine 2025; (30(6)):1246-1265 doi:10.1080/13548506.2024.2447009.

    PMID: 39731482
  31. 31

    Simultaneous bilateral branch retinal artery occlusion as a manifestation of sickle cell crisis: diagnostic and therapeutic implications.

    Sousa Gonçalves M, Aerts F, Beltran B

    BMJ case reports 2025; (18(8)) doi:10.1136/bcr-2025-267532.

    PMID: 40866088
  32. 32

    Newly Diagnosed Hemoglobin SC Disease Presenting With Choledocholithiasis With Acute Obstructive Cholangitis: A Case Report.

    Tran DT, Youn JJ, Thompson G

    Cureus 2025; (17(5)):e84040 doi:10.7759/cureus.84040.

    PMID: 40510090

This page provides general long-term monitoring guidelines for Hemoglobin C and HbSC for educational purposes. Always consult your hematologist to create a surveillance schedule tailored to your specific health needs.

Stay up to date

Get notified when new research about Hemoglobin C disease is published.

No spam. Unsubscribe anytime.